| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;40:619.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Epidemiology and Biostatistics, Case Western Reserve University (N.J.S., D.F., B.T.), Cleveland, Ohio; The Program for Population Genetics and Department of Biostatistics, Harvard University School of Public Health (N.J.S.), Boston, Mass; The Jackson Laboratory (N.J.S.), Bar Harbor, Maine; and Hypertension Research Center (J.P.G., L.Z., A.A.) and Department of Microbiology and Molecular Genetics (H.J.), University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark. Dr Fallin is now at the Department of Epidemiology, Johns Hopkins University, Baltimore, Md. Dr Schork is now at the Department of Psychiatry, University of California at San Diego.
Correspondence to Abraham Aviv, MD, Room F-464, MSB, Hypertension Research Center, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 S Orange Ave, Newark, NJ 07103. E-mail avivab{at}umdnj.edu
Little is known about genetic determinants explaining variation in the erythrocyte sodium-lithium countertransport (SLC), an intermediate phenotype of essential hypertension. We characterized the SLC in immortalized lymphoblasts and showed that its behavior is similar to that of erythrocyte SLC. We then performed association and linkage analyses of the SLC in immortalized lymphoblasts from 5 large pedigrees from the Center dEtude du Polymorphisme Humain (CEPH) genomics repository. The results of these analyses showed that a number of genomic regions harboring genes involved in glutathione metabolism might explain variations in SLC activity. These findings support evidence that thiol groups play a central role in SLC activity.
Key Words: oxidative stress ion transport lymphocytes glutathione intermediate phenotype
This article has been cited by other articles:
![]() |
K. Kazadi, C. Loeuillet, S. Deutsch, A. Ciuffi, M. Munoz, J. S. Beckmann, D. Moradpour, S. E. Antonarakis, and A. Telenti Genomic determinants of the efficiency of internal ribosomal entry sites of viral and cellular origin Nucleic Acids Res., December 1, 2008; 36(21): 6918 - 6925. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, F. Rao, J. L. Rodriguez-Flores, M. Mahata, M. M. Fung, M. Stridsberg, S. M. Vaingankar, G. Wen, R. M. Salem, M. Das, et al. Naturally Occurring Human Genetic Variation in the 3'-Untranslated Region of the Secretory Protein Chromogranin A Is Associated With Autonomic Blood Pressure Regulation and Hypertension in a Sex-Dependent Fashion J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xiang, M. Feng, S. Muend, and R. Rao A human Na+/H+ antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension PNAS, November 20, 2007; 104(47): 18677 - 18681. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Walgren, M. A. Meucci, and H. L. McLeod Pharmacogenomic Discovery Approaches: Will the Real Genes Please Stand Up? J. Clin. Oncol., October 10, 2005; 23(29): 7342 - 7349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Watters, A. Kraja, M. A. Meucci, M. A. Province, and H. L. McLeod Genome-wide discovery of loci influencing chemotherapy cytotoxicity PNAS, August 10, 2004; 101(32): 11809 - 11814. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Greenwood, P. E. Cadman, M. Stridsberg, S. Nguyen, L. Taupenot, N. J. Schork, and D. T. O'Connor Genome-wide linkage analysis of chromogranin B expression in the CEPH pedigrees: implications for exocytotic sympathochromaffin secretion in humans Physiol Genomics, June 17, 2004; 18(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |